Meeting
2016 Genitourinary Cancers Symposium
Mapping prostate cancer (CaP) recurrence after prostatectomy with c-11 choline PET/CT and 3T pelvic MRI in the contemporary era.
Authors
Ilya Sobol
Mayo Clinic, Rochester, MN
Ilya Sobol , Rimki Haloi , Sean Sunghun Park , Boyd Viers , Brian Davis , Lance A Mynderse , Stephen A. Boorjian , Robert Houston Thompson , Matthew K. Tollefson , Matthew Gettman , Fernando Quevedo , Adam Froemming , Val J. Lowe , Igor Frank , R. Jeffrey Karnes , Eugene D. Kwon
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Advanced Disease
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 255)
DOI
10.1200/jco.2016.34.2_suppl.255
Abstract #
255
Poster Bd #
L4
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Independent blinded validation of an AI-based digital histology classifier for prostate cancer recurrence and metastasis risk prediction.
First Author: Magdalena Fay
Poster
2024 ASCO Genitourinary Cancers Symposium
Long-term results of radiation with or without anti-androgens (AAT) in patients receiving salvage prostate bed radiation therapy (sRT) post prostatectomy.
First Author: Himu Lukka
Poster
2023 ASCO Genitourinary Cancers Symposium
Use of prostate cancer subtyping by gene expression to predict response to radiation and chemohormonal therapies.
First Author: Adam B Weiner
Poster
2022 ASCO Genitourinary Cancers Symposium
Impact of AR-V7 and other androgen receptor splice variant expression on outcomes of post-prostatectomy salvage therapy.
First Author: Keisuke Otani